Holdings
Braidwell LP
As of Jun 30, 2026, Braidwell LP reported 77 positions worth US$2.54B. Largest: Caris Life Sciences, Inc., Hinge Health, Inc. and Glaukos Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Caris Life Sciences, Inc. | 8.26M | US$147M | +247K | Jun 30, 2026 |
| Hinge Health, Inc. | 1.33M | US$110M | −125K | Jun 30, 2026 |
| Glaukos Corporation | 592K | US$82.7M | −172K | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 2M | US$81.1M | −351K | Jun 30, 2026 |
| Spyre Therapeutics, Inc. | 879K | US$78.1M | −53,356 | Jun 30, 2026 |
| Irhythm Holdings, Inc. | 654K | US$77.8M | +44,070 | Jun 30, 2026 |
| Neogenomics, Inc. | 4.92M | US$71.8M | −699K | Jun 30, 2026 |
| Kodiak Sciences Inc | 1.79M | US$69.6M | −31,347 | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 1.13M | US$68.3M | −207K | Jun 30, 2026 |
| Monte Rosa Therapeutics, Inc. | 2.45M | US$59.3M | −755K | Jun 30, 2026 |